Methylation of BRCA1 Promoter Region Is Associated with Unfavorable Prognosis in Women with Early-Stage Breast Cancer

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Hsu, Nicholas C ^a   Huang, Ya Fang ^b   Yokoyama, Kazunari K ^a   Chu, Pei Yi ^c   Chen, Fang Ming ^b   Hou, Ming Feng ^b,d,e  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c ST MARTIN DE PORRES HOSPITAL   (Taiwan)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^e KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE FREE SURVIVAL; DNA EXTRACTION; DNA METHYLATION; EARLY CANCER; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PROMOTER REGION; TRIPLE NEGATIVE BREAST CANCER; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

ADULT; AGED; BRCA1 PROTEIN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DNA METHYLATION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MIDDLE AGED; MUTATION; NEOPLASM GRADING; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS, GENETIC; SURVIVAL RATE; YOUNG ADULT;

EID: 84873543143     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056256     Document Type: Article

References (40)

1. (2012) Cancer Registry Annual Report, 2009 Taiwan. In: Health Do, editor.
2. Shen YC, Chang CJ, Hsu C, Cheng CC, Chiu CF, et al. (2005) Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: implications from age-period-cohort analysis. Cancer Epidemiol Biomarkers Prev 14: 1986-1990.
3. Fong M, Henson DE, Devesa SS, Anderson WF, (2006) Inter- and intra-ethnic differences for female breast carcinoma incidence in the continental United States and in the state of Hawaii. Breast Cancer Res Treat 97: 57-65.
4. Honrado E, Osorio A, Palacios J, Benitez J, (2006) Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations. Oncogene 25: 5837-5845.
5. Lynch HT, Silva E, Snyder C, Lynch JF, (2008) Hereditary breast cancer: part I. Diagnosing hereditary breast cancer syndromes. Breast J 14: 3-13.
6. Chen W, Pan K, Ouyang T, Li J, Wang T, et al. (2009) BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer. Breast Cancer Res Treat 117: 55-60.
7. Toh GT, Kang P, Lee SS, Lee DS, Lee SY, et al. (2008) BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history. PLoS One 3: e2024.
8. Ahn SH, Son BH, Yoon KS, Noh DY, Han W, et al. (2007) BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations. Cancer Lett 245: 90-95.
9. Liede A, Narod SA, (2002) Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2. Hum Mutat 20: 413-424.
10. Rennert G, Bisland-Naggan S, Barnett-Griness O, Bar-Joseph N, Zhang S, et al. (2007) Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 357: 115-123.
11. Li SS, Tseng HM, Yang TP, Liu CH, Teng SJ, et al. (1999) Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan. Hum Genet 104: 201-204.
12. Chen ST, Chen RA, Kuo SJ, Chien YC, (2003) Mutational screening of breast cancer susceptibility gene 1 from early onset, bi-lateral, and familial breast cancer patients in Taiwan. Breast Cancer Res Treat 77: 133-143.
13. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, et al. (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62: 676-689.
14. Hedenfalk I, Ringner M, Ben-Dor A, Yakhini Z, Chen Y, et al. (2003) Molecular classification of familial non-BRCA1/BRCA2 breast cancer. Proc Natl Acad Sci U S A 100: 2532-2537.
15. Easton DF, Bishop DT, Ford D, Crockford GP, (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 52: 678-701.
16. Narod SA, Ford D, Devilee P, Barkardottir RB, Lynch HT, et al. (1995) An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. Am J Hum Genet 56: 254-264.
17. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP, (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72: 141-196.
18. Jones PA, Laird PW, (1999) Cancer epigenetics comes of age. Nat Genet 21: 163-167.
19. Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, et al. (2000) Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92: 564-569.
20. Matros E, Wang ZC, Lodeiro G, Miron A, Iglehart JD, et al. (2005) BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles. Breast Cancer Res Treat 91: 179-186.
21. Rice JC, Massey-Brown KS, Futscher BW, (1998) Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene 17: 1807-1812.
22. Rice JC, Ozcelik H, Maxeiner P, Andrulis I, Futscher BW, (2000) Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis 21: 1761-1765.
23. Wei M, Grushko TA, Dignam J, Hagos F, Nanda R, et al. (2005) BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. Cancer Res 65: 10692-10699.
24. Barekati Z, Radpour R, Lu Q, Bitzer J, Zheng H, et al. (2012) Methylation signature of lymph node metastases in breast cancer patients. BMC Cancer 12: 244.
25. Bal A, Verma S, Joshi K, Singla A, Thakur R, et al. (2012) BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression. Virchows Arch 461: 305-312.
26. Krasteva ME, Bozhanov SS, Antov GG, Gospodinova ZI, Angelov SG, (2012) Breast cancer patients with hypermethylation in the promoter of BRCA1 gene exhibit favorable clinical status. Neoplasma 59: 85-91.
27. Mirza S, Sharma G, Prasad CP, Parshad R, Srivastava A, et al. (2007) Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Life Sci 81: 280-287.
28. Xu CF, Brown MA, Chambers JA, Griffiths B, Nicolai H, et al. (1995) Distinct transcription start sites generate two forms of BRCA1 mRNA. Hum Mol Genet 4: 2259-2264.
29. Catteau A, Harris WH, Xu CF, Solomon E, (1999) Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 18: 1957-1965.
30. Krop I, Maguire P, Lahti-Domenici J, Lodeiro G, Richardson A, et al. (2003) Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors. Cancer Res 63: 2024-2027.
31. Birgisdottir V, Stefansson OA, Bodvarsdottir SK, Hilmarsdottir H, Jonasson JG, et al. (2006) Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Breast Cancer Res 8: R38.
32. van der Groep P, Bouter A, van der Zanden R, Siccama I, Menko FH, et al. (2006) Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data. J Clin Pathol 59: 611-617.
33. Atchley DP, Albarracin CT, Lopez A, Valero V, Amos CI, et al. (2008) Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol 26: 4282-4288.
34. Miyoshi Y, Murase K, Oh K, (2008) Basal-like subtype and BRCA1 dysfunction in breast cancers. Int J Clin Oncol 13: 395-400.
35. Johannsson OT, Idvall I, Anderson C, Borg A, Barkardottir RB, et al. (1997) Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur J Cancer 33: 362-371.
36. Sobol H, Stoppalyonnet D, Bressacdepaillerets B, Peyrat J, Guinebretiere J, et al. (1997) BRCA1-p53 relationship in hereditary breast cancer. Int J Oncol 10: 349-353.
37. Veronesi A, de Giacomi C, Magri MD, Lombardi D, Zanetti M, et al. (2005) Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases. BMC Cancer 5: 70.
38. Verhoog LC, Brekelmans CT, Seynaeve C, van den Bosch LM, Dahmen G, et al. (1998) Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 351: 316-321.
39. Shavers VL, Harlan LC, Stevens JL, (2003) Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer 97: 134-147.
40. Mehrotra J, Ganpat MM, Kanaan Y, Fackler MJ, McVeigh M, et al. (2004) Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women. Clin Cancer Res 10: 2052-2057.